ATE508140T1 - Anti-idiotypische antikörper gegen faktor-viii- hemmer und deren verwendungen - Google Patents

Anti-idiotypische antikörper gegen faktor-viii- hemmer und deren verwendungen

Info

Publication number
ATE508140T1
ATE508140T1 AT03784106T AT03784106T ATE508140T1 AT E508140 T1 ATE508140 T1 AT E508140T1 AT 03784106 T AT03784106 T AT 03784106T AT 03784106 T AT03784106 T AT 03784106T AT E508140 T1 ATE508140 T1 AT E508140T1
Authority
AT
Austria
Prior art keywords
factor viii
antibodies
inhibitory
present
idiotypic antibodies
Prior art date
Application number
AT03784106T
Other languages
English (en)
Inventor
Jean-Guy Gilles
Jean-Marie Saint-Remy
Marc Jacquemin
Original Assignee
Life Sciences Res Partners
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Life Sciences Res Partners filed Critical Life Sciences Res Partners
Application granted granted Critical
Publication of ATE508140T1 publication Critical patent/ATE508140T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4208—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig
    • C07K16/4241—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an idiotypic determinant on Ig against anti-human or anti-animal Ig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT03784106T 2002-07-31 2003-07-28 Anti-idiotypische antikörper gegen faktor-viii- hemmer und deren verwendungen ATE508140T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02447150A EP1388544A1 (de) 2002-07-31 2002-07-31 Anti-Idiotypische Antikörper gegen Factor VIII-Inhibitor und Verwendungen davon
PCT/EP2003/008365 WO2004014955A1 (en) 2002-07-31 2003-07-28 Anti-idiotypic antibodies against factor viii inhibitor and uses thereof

Publications (1)

Publication Number Publication Date
ATE508140T1 true ATE508140T1 (de) 2011-05-15

Family

ID=30129275

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03784106T ATE508140T1 (de) 2002-07-31 2003-07-28 Anti-idiotypische antikörper gegen faktor-viii- hemmer und deren verwendungen

Country Status (11)

Country Link
US (1) US7582296B2 (de)
EP (2) EP1388544A1 (de)
JP (1) JP2006515565A (de)
AT (1) ATE508140T1 (de)
AU (1) AU2003260335B2 (de)
CA (1) CA2494698C (de)
DE (1) DE60337030D1 (de)
DK (1) DK1581560T3 (de)
ES (1) ES2366280T3 (de)
PT (1) PT1581560E (de)
WO (1) WO2004014955A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004010050A1 (de) * 2004-03-02 2005-09-22 Bayer Healthcare Ag Spezifische monoklonale und polyklonale Antikörper für Repinotan und dessen ringoffene Form
FR2889534B1 (fr) * 2005-08-04 2012-11-02 Lab Francais Du Fractionnement Anticorps anti-idiotypique neutralisant l'activite inhibitrice d'un anticorps inhibiteur du facteur viii
FR2892724B1 (fr) 2005-11-02 2008-01-04 Lab Francais Du Fractionnement Anticorps cytotoxiques diriges contre des anticorps inhibiteurs du facteur viii.
FR2897868B1 (fr) * 2006-02-24 2012-08-31 Lab Francais Du Fractionnement Anticorps anti-idiotypiques neutralisant l'activite inhibitrice d'un anticorps inhibiteur dirige contre le domaine c1 du facteur viii.
JP2010536363A (ja) * 2007-08-23 2010-12-02 エルエフビー バイオテクノロジース ファクターｖｉｉｉのｃ１ドメインに対する阻害抗体の阻害活性を中性化する抗イデオタイプ抗体
GB201216002D0 (en) 2012-09-07 2012-10-24 Deutsches Rheuma Forschungszentrum Berlin Drfz Compositions adn methods

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639641A (en) * 1992-09-09 1997-06-17 Immunogen Inc. Resurfacing of rodent antibodies
US6210671B1 (en) * 1992-12-01 2001-04-03 Protein Design Labs, Inc. Humanized antibodies reactive with L-selectin
IT1277827B1 (it) * 1995-03-01 1997-11-12 Ministero Uni Ricerca Scient E Anticorpo monoclonale chimerico murino/umano o un suo frammento specifico per il recettore egf (egf-r)
DK0766745T3 (da) * 1995-04-08 2002-11-25 Lg Chemical Ltd Monoklonalt antistof, som er specifikt for humant 4-1BB samt cellelinje, som producerer dette
ES2233974T3 (es) * 1995-09-11 2005-06-16 Kyowa Hakko Kogyo Co., Ltd. Anticuerpo contra la cadena alfa del receptor de la interleucina 5 humana.
JP3683278B2 (ja) * 1995-12-20 2005-08-17 ザ ユニバーシティ オブ ケンタッキー リサーチ ファウンデーション マウスモノクローナル抗イディオタイプ抗体１１ｄ１０およびその使用方法
PT1095143E (pt) * 1998-05-08 2008-11-28 Sanquin Bloedvoorziening Inibidor para o diagnóstico e tratamento de doentes com hemofilia a
WO2001004269A1 (en) 1999-07-14 2001-01-18 D. Collen Research Foundation Vzw Ligands for use in therapeutic compositions for the treatment of hemostasis disorders
EP1197755A1 (de) * 2000-10-11 2002-04-17 Pepscan Systems B.V. Bestimmung von Protein-Bindungsstellen

Also Published As

Publication number Publication date
ES2366280T3 (es) 2011-10-18
US7582296B2 (en) 2009-09-01
DE60337030D1 (de) 2011-06-16
CA2494698A1 (en) 2004-02-19
US20060239998A1 (en) 2006-10-26
EP1581560B1 (de) 2011-05-04
AU2003260335A1 (en) 2004-02-25
WO2004014955A1 (en) 2004-02-19
EP1581560A1 (de) 2005-10-05
CA2494698C (en) 2011-03-15
PT1581560E (pt) 2011-08-17
WO2004014955A9 (en) 2005-03-24
DK1581560T3 (da) 2011-08-22
JP2006515565A (ja) 2006-06-01
EP1388544A1 (de) 2004-02-11
AU2003260335B2 (en) 2009-01-08

Similar Documents

Publication Publication Date Title
DE60327999D1 (de) Azolylaminoazine als inhibitoren von proteinkinasen
NO20034056D0 (no) Proliferative sykdommer
DK1955700T3 (da) Terapeutisk behandling af androgenreceptor-betingede lidelser
ATE536188T1 (de) Fcgammariib-spezifische antikörper und verfahren zur verwendung davon
DE602004014117D1 (de) Thiazole zur verwendung als inhibitoren von protein-kinasen
ATE466580T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE468336T1 (de) Azolylaminoazine als proteinkinasehemmer
ATE365733T1 (de) Zusammensetzungen brauchbar als protein-kinase- inhibitoren
EA200602062A1 (ru) Амидосоединения и их применение в качестве фармацевтических средств
DE602004010407D1 (de) Fluorsubstituierter omega-carboxyaryldiphenylharnstoff zur behandlung und prävention von krankheiten und leiden
CY1112238T1 (el) Αναστολεις μιτωτικης κινεσινης και μεθοδοι χρησης αυτων
CY1112055T1 (el) Συνθεσεις και μεθοδοι για την διαγνωση και θεραπευτικη αγωγη ογκου πνευμονα
SI1943219T1 (sl) Inhibitorji 5-lipoksigenazo aktivirnega proteina (FLAP)
ATE508114T1 (de) Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung
ATE420097T1 (de) Substituierte sapogenine und ihre verwendung
DE60137337D1 (de) Vorbeugende und therapeutsche monoklonale antikörper gegen vacciniavirusantigene
BR0307508A (pt) Composto, composição farmacêutica, e, métodos de tratamento ou prevenção de dor e inflamação e de tratamento de doença
MY147669A (en) Anti-alpha2 integrin antibodies and their uses
ATE534635T1 (de) N-pyrazinyl-phenylsulfonamide und deren verwendung zur behandlung von durch chemokine vermittelten krankheiten
EE200100179A (et) Farmatseutilised agendid Parkinsoni tõve, ADHD jamikroadenoomide raviks
DE602004017326D1 (de) Tetrahydrocarbazolderivate und deren pharmazeutische verwendung
ATE435020T1 (de) Oligo-beta-(1,3)-glucan und monoklonale antikörper gegen krebs
ATE365748T1 (de) Polymer-konjugate von neublastin und methoden für deren verwendung
DE60206289D1 (de) Verwendung von bibn4096 in kombination mit anderen migränemitteln zur behandlung von migräne
ATE508140T1 (de) Anti-idiotypische antikörper gegen faktor-viii- hemmer und deren verwendungen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1581560

Country of ref document: EP